| Product NDC: | 0186-0450 |
| Proprietary Name: | PLENDIL |
| Non Proprietary Name: | Felodipine |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Felodipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0186-0450 |
| Labeler Name: | AstraZeneca LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019834 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19941004 |
| Package NDC: | 0186-0450-58 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (0186-0450-58) |
| NDC Code | 0186-0450-58 |
| Proprietary Name | PLENDIL |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (0186-0450-58) |
| Product NDC | 0186-0450 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Felodipine |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19941004 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca LP |
| Substance Name | FELODIPINE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |